Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant
J.-Y. Dube, F. McIntosh, J. G. Zarruk, S. David, J. Nigou, M. A. Behr
Abstract
Complete Freunds adjuvant (CFA) has historically been one of the most useful tools of immunologists. Essentially comprised of dead mycobacteria and mineral oil, we asked ourselves what is special about the mycobacterial part of this adjuvant, and could it be recapitulated synthetically? Here, we demonstrate the essentiality of N-glycolylated peptidoglycan plus trehalose dimycolate (both unique in mycobacteria) for the complete adjuvant effect using knockouts and chemical complementation. A combination of synthetic N-glycolyl muramyl dipeptide and minimal trehalose dimycolate motif GlcC14C18 was able to upregulate dendritic cell effectors, plus induce experimental autoimmunity qualitatively similar but quantitatively milder compared to CFA. This research outlines how to substitute CFA with a consistent, molecularly-defined adjuvant which may inform the design of immunotherapeutic agents and vaccines benefitting from cell-mediated immunity. We also anticipate using synthetic microbe-associated molecular patterns (MAMPs) to study mycobacterial immunity and immunopathogenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Adjuvant effects of multifunctional transcription factor and BCG target YB-1: exogenous YB-1 enhances specific antibody production in vivo and protects mice against lethal E. coli challenge
A. O. Shepelyakovskaya, L. Alekseeva, … A. G. Laman·bioRxiv·Nov 9, 2022
- De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis
T. Laval, L. Pedro-Cos, … C. Demangel·bioRxiv·Jul 8, 2021
- Intranasal immunization with CPAF combined with cyclic-di-AMP induces a memory CD4 T cell response and reduces bacterial burden following intravaginal infection with Chlamydia muridarum
Taylor B. Poston, Jenna Girardi, … Toni L. Darville·VaccinePeer-reviewed·Nov 12, 2024
- Amphiphile-engineered DNA adjuvants stimulate strong type I IFN production in lymph nodes via cytosolic danger-sensing to induce potent cellular and humoral immunity in mice and non-human primates
Martin Peter Steinbuck, Lochana M. Seenappa, … Peter C. DeMuth·Science AdvancesPeer-reviewed·May 29, 2026
- Semi-synthetic glycoconjugate vaccine candidate against Cryptococcus neoformans
Conor J. Crawford, Livia Liporagi-Lopes, … Arturo Casadevall·ACS Infectious DiseasesPeer-reviewed·May 31, 2024
- Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity
D. H. Quan, C. Counoupas, … J. A. Triccas·bioRxiv·Oct 1, 2020